The nation of Zimbabwe has rejected a significant American health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's request for sensitive information.
The decision was revealed after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
A government spokesman has since explained that the United States was requesting genetic material for scientific study and commercial purposes while refused to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for more negotiations to reach a agreement suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision follows a comparable situation in Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the security of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
As per statements, 16 nations in Africa have so far agreed to these new agreements, representing over $18.3bn of fresh investment.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided immense advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our nation would provide the raw materials for medical research without any assurance that the end products would be available to our citizens if a new health crisis emerge."
Sovereignty and Global Health
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already established via the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This framework is designed to ensure that when a country contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.
"We are open to further dialogue with our US partners on how future collaboration might be arranged in a manner that honours the sovereignty and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that talks need to persist considering much of the nation's Aids initiatives relied on foreign aid.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed through technical clarification and mutually agreed protections," it commented.
The situation emphasises the continuing tensions between accepting much-needed foreign assistance and safeguarding local interests in an increasingly data-driven world.